Profitability Ratios
| Ratio |
Value |
| GP Margin |
78.7% |
| EBIT Margin |
-873.9% |
| EBITDA Margin |
-864.3% |
| Operating Margin |
-873.9% |
| Pretax Margin |
-765.9% |
| Cont. Ops Margin |
-764.0% |
| Net Margin |
-764.0% |
| Bottom Line Margin |
-764.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
11.46 |
| Quick Ratio |
11.06 |
| Solvency Ratio |
-3.915 |
| Cash Ratio |
1.08 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.02 |
| Forward PEG |
0.02 |
| Price/Book |
1.32 |
| Price/Sales |
29.21 |
| Price/FCF |
-4.18 |
| Price/Op Cash Flow |
-4.23 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0478 |
| Debt/Equity |
0.0520 |
| Debt/Capital |
0.0494 |
| Long-Term Debt/Capital |
0.0180 |
| Financial Leverage |
1.09 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.06 |
| Operating Cash Flow Ratio |
-4.537 |
| Operating Cash Flow/Sales |
-690.3% |
| Free Cash Flow/Operating Cash Flow |
101.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-25.33 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
-20.28 |
| Operating Cash Flow Coverage |
-6.01 |
| Capital Expenditure Coverage |
-86.42 |
| Dividend + Capital Expenditure Coverage |
-86.42 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.93 |
| EPS |
-7.120 |
| Debt/Share |
1.0699 |
| Cash/Share |
14.74 |
| Book Value/Share |
20.58 |
| Tangible BV/Share |
20.58 |
| Equity/Share |
20.58 |
| Operating Cash Flow/Share |
-6.434 |
| Capital Expenditure/Share |
0.074 |
| FCF/Share |
-6.508 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.998 |
| Earnings Before Tax/EBIT |
0.876 |
| Price/Fair Value |
1.32 |
| Debt/Market Cap |
0.0255 |
| Effective Tax Rate |
0.2% |
| Enterprise Value Multiple |
-3.32 |
AGIO - Agios Pharmaceuticals, Inc.